Assessment of panobacumab as adjunctive immunotherapy for the treatment of nosocomial Pseudomonas aeruginosa pneumoniaYok‐Ai Que, Philippe Eggimann, Hedvika Lazar et al.|European Journal of Clinical Microbiology & Infectious Diseases|2014Cited by 78
Epidemiology, risk factors and clinical course of SARS-CoV-2 infected patients in a Swiss university hospital: An observational retrospective studyJean Regina, Loïc Lhopitallier, David Haefliger et al.|PLoS ONE|2020Cited by 64
Serial measurement of pancreatic stone protein for the early detection of sepsis in intensive care unit patients: a prospective multicentric studyJérôme Pugin, Bruno François, Thomas Daix et al.|Critical Care|2021Cited by 62
Transcriptomic Signature Differences Between SARS-CoV-2 and Influenza Virus Infected PatientsStéphanie Bibert, Nicolas Guex, João Lourenço et al.|Frontiers in Immunology|2021Cited by 45
Epidemiology, risk factors and clinical course of SARS-CoV-2 infected patients in a Swiss university hospital: an observational retrospective studyJean Regina, Loïc Lhopitallier, Matthaios Papadimitriou‐Olivgeris et al.|medRxiv|2020Cited by 39